New device aims to stop bleeding after prostate surgery
NCT ID NCT07287488
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new device designed to control bleeding after prostate surgery (TURP). The device applies steady pressure to the urethra using a catheter. Researchers will compare it to standard methods on mannequins. Sixty healthcare workers will evaluate how easy, safe, and stable the device is to use.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Innovative Urethral Catheter Traction Device
- What this could lead to
- If successful, this device could offer a safer, easier way to control bleeding after prostate surgery, improving patient recovery and reducing complications.
- What could go wrong
- This is a small simulation study on mannequins, not real patients. The device may not work as well in actual surgery or may have unforeseen issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Feb 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Active operating room nurse or urology specialist physician. * Experienced in urethral catheter application. * Signed informed consent form voluntarily. Exclusion Criteria: * Individuals who do not wish to participate or withdraw consent during the study. * Individuals who do not meet the inclusion criteria.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Ankara Etlik Şehir Hastanesi
RECRUITINGAnkara, Yenimahalle, 06170, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Laser prostate surgery that spares ejaculation put to a Five-Year test
- Virtual basket laser mode put to the test for faster prostate surgery
- Steam therapy vs. surgery: can a less invasive fix help men with blocked urine flow?
- Listening to patients: a new way to guide prostate treatment?
- A surgical twist that could save ejaculation during prostate surgery
- Water jet surgery: a new wave for prostate relief?